These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 30803031)
21. Pharmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects. Khosravan R; Grabowski BA; Wu JT; Joseph-Ridge N; Vernillet L Clin Pharmacokinet; 2006; 45(8):821-41. PubMed ID: 16884320 [TBL] [Abstract][Full Text] [Related]
22. [Analysis of uric acid and oxypurines in normal subjects and in gout patients]. Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E Boll Soc Ital Biol Sper; 1989 Dec; 65(12):1201-5. PubMed ID: 2627336 [TBL] [Abstract][Full Text] [Related]
23. An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study. Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S13-8. PubMed ID: 21654265 [TBL] [Abstract][Full Text] [Related]
24. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease. Torres RJ; Puig JG Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316 [TBL] [Abstract][Full Text] [Related]
25. Reduction of urinary uric acid excretion in patients with proteinuria. Zou H; Xiang M; Ye X; Xiong Y; Xie B; Shao J J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Dec; 1006():59-64. PubMed ID: 26523664 [TBL] [Abstract][Full Text] [Related]
26. Evaluation and characterization of the effects of ticagrelor on serum and urinary uric acid in healthy volunteers. Butler K; Teng R Clin Pharmacol Ther; 2012 Feb; 91(2):264-71. PubMed ID: 22190065 [TBL] [Abstract][Full Text] [Related]
27. [Hyperuricemia and gout--diagnosis]. Gröbner W; Walter-Sack I Dtsch Med Wochenschr; 2002 Feb; 127(5):207-9. PubMed ID: 11821993 [No Abstract] [Full Text] [Related]
28. Renal excretion is a cause of decreased serum uric acid during acute gout. Zhao T; Lv X; Cao L; Guo M; Zheng S; Xue Y; Zou H; Wan W; Zhu X Int J Rheum Dis; 2018 Sep; 21(9):1723-1727. PubMed ID: 30345643 [TBL] [Abstract][Full Text] [Related]
29. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. Nan H; Qiao Q; Dong Y; Gao W; Tang B; Qian R; Tuomilehto J J Rheumatol; 2006 Jul; 33(7):1346-50. PubMed ID: 16821269 [TBL] [Abstract][Full Text] [Related]
30. [Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver]. Mertz DP Fortschr Med; 1983 May; 101(18):851-3. PubMed ID: 6862346 [No Abstract] [Full Text] [Related]
31. High-performance liquid chromatographic determination of hypoxanthine and xanthine in biological fluids. Boulieu R; Bory C; Baltassat P; Gonnet C J Chromatogr; 1982 Dec; 233():131-40. PubMed ID: 6897651 [TBL] [Abstract][Full Text] [Related]
32. Effects of long-term beer ingestion on plasma concentrations and urinary excretion of purine bases. Ka T; Moriwaki Y; Takahashi S; Yamamoto A; Tsutsumi Z; Inokuchi T; Yamamoto T Horm Metab Res; 2005 Oct; 37(10):641-5. PubMed ID: 16278788 [TBL] [Abstract][Full Text] [Related]
33. Associations of plasma uric acid and purine metabolites with blood pressure in children: the KOALA Birth Cohort Study. Scheepers LE; Boonen A; Pijnenburg W; Bierau J; Staessen JA; Stehouwer CD; Thijs C; Arts IC J Hypertens; 2017 May; 35(5):982-993. PubMed ID: 28355168 [TBL] [Abstract][Full Text] [Related]
34. Simultaneous determination of uric acid, xanthine and hypoxanthine at poly(pyrocatechol violet)/functionalized multi-walled carbon nanotubes composite film modified electrode. Wang Y Colloids Surf B Biointerfaces; 2011 Dec; 88(2):614-21. PubMed ID: 21856133 [TBL] [Abstract][Full Text] [Related]
35. Study on the anti-gout activity of chlorogenic acid: improvement on hyperuricemia and gouty inflammation. Meng ZQ; Tang ZH; Yan YX; Guo CR; Cao L; Ding G; Huang WZ; Wang ZZ; Wang KD; Xiao W; Yang ZL Am J Chin Med; 2014; 42(6):1471-83. PubMed ID: 25384446 [TBL] [Abstract][Full Text] [Related]
36. Study on the relationship between FFA and gout flare. Pei L; Xie L; Wu J; Zhang H; Zhang X Clin Rheumatol; 2020 Apr; 39(4):1251-1255. PubMed ID: 32016654 [TBL] [Abstract][Full Text] [Related]
38. Diurnal Variations in Serum Uric Acid, Xanthine, and Xanthine Oxidoreductase Activity in Male Patients with Coronary Artery Disease. Shimizu M; Naito R; Sato A; Ishiwata S; Yatsu S; Shitara J; Matsumoto H; Murata A; Kato T; Suda S; Hiki M; Kuwabara M; Murase T; Nakamura T; Kasai T Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892555 [TBL] [Abstract][Full Text] [Related]
39. Metabolite target analysis of human urine combined with pattern recognition techniques for the study of symptomatic gout. Liu Y; Yu P; Sun X; Di D Mol Biosyst; 2012 Nov; 8(11):2956-63. PubMed ID: 22932763 [TBL] [Abstract][Full Text] [Related]
40. Purine metabolism in patients with gout: the role of lead. Miranda-Carús E; Mateos FA; Sanz AG; Herrero E; Ramos T; Puig JG Nephron; 1997; 75(3):327-35. PubMed ID: 9069456 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]